Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome

Completed · Phase 2

Conditions studied: Shoulder Impingement Syndrome

In brief

The purpose of the study is to explore the potential usefulness of a heated lidocaine 70 mg/tetracaine 70 mg topical patch for the treatment of pain associated with shoulder impingement syndrome

Key facts

Study ID

NCT01055444

Run by

ZARS Pharma Inc.

People needed

20

Starts

2010-03-01

Expected to finish

2010-09-01

Last updated by the study team

2012-03-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pain associated with shoulder impingement syndrome in a single shoulder
• Have tenderness at the attachment site of the rotator cuff tendons in the affected shoulder
• Have positive Hawkins and Neers signs

You may not qualify if…

• Have used any topically applied pain medication on the target treatment area within 3 days preceding the Screening/Baseline visit
• Have used any injected pain medication within 14 days preceding the Screening/Baseline visit
• Are receiving class 1 antiarrhythmic drugs (ie, tocainide, mexiletine, etc.)
• Have a history of and/or past diagnosis of severe hepatic disease
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• Injury Care Medical Center — Boise, Idaho, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.